CS Diagnostics (OTCQB: CSDX) CS-Protect Hydrogel FDA Approval on Fasttrack – GNPX, BON, SES, BETR.C – Stocks to Watch
CS Diagnostics Corp. (OTCQB: CSDX) has engaged Lachman Consultants Inc. to support FDA approval for its CS-Protect Hydrogel, an innovative organ spacer medical device designed to enhance radiation therapy…
